Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.88 CAD | -1.06% | -4.05% | -26.74% |
May. 13 | Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating | MT |
May. 10 | National Bank Reviews Docebo's Q1 -- Trims Target to US$55 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 70.14 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 6.17 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.74% | 1.04B | B- | ||
+8.91% | 85.92B | B | ||
+5.14% | 77.93B | B+ | ||
-16.20% | 52.89B | B+ | ||
+26.18% | 48.28B | D+ | ||
+28.93% | 45.38B | D+ | ||
-34.05% | 40.83B | B- | ||
+66.72% | 38.78B | D+ | ||
-0.36% | 27.48B | C+ | ||
-26.47% | 21.52B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- DCBO Stock
- Ratings Docebo Inc.